Digital representation of chemical mixtures to aid drug discovery and formulation
化学混合物的数字表示以帮助药物发现和配制
基本信息
- 批准号:9902210
- 负责人:
- 金额:$ 74.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-12-19 至 2021-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAdoptionAllyBooksCatalogsChemical StructureChemicalsChemistryCodeCommercial CatalogsComputer softwareComputersDataDatabasesDevelopmentDiseaseDrug FormulationsDrug IndustryElementsEnglish LanguageEquipment and supply inventoriesGoalsGovernmentHumanIndividualIndustryInfrastructureIntelligenceInternationalLaboratoriesManufacturer NameMethodsModelingMolecular StructureNamesPharmaceutical PreparationsPharmacologic SubstancePhasePolymersProcessReadabilityReagentResearchResearch PersonnelRiskSafetyScientistServicesShorthandSolventsSpecific qualifier valueStructureSupervisionSystemTechnologyTextTimeToxic effectToxicologyTractionTranslationsVendorVisioncofactorcomputerized toolsconsumer productcostdata structuredeep learningdigitaldrug discoveryexperimental studyfirst responderimprovedindexinginnovationinteroperabilitymalemedical specialtiesmembernatural languagenovelopen sourcequality assurancestructured datatool
项目摘要
PROJECT SUMMARY
Collaborative Drug Discovery, Inc. (CDD) proposes to develop a suite of software modules to enable scientists
to unambiguously represent chemical mixtures in standard machine-readable formats, filling an urgent and
widely-recognized need. Chemicals are typically formulated as mixtures. Recording and communicating infor-
mation about chemical mixtures is essential for scientists and support staff in the pharmaceutical industry, in
academia, in non-profit research organizations, in government, at specialty chemical vendors, and at commer-
cial manufacturers to:
• discover, develop, formulate, manufacture and regulate drugs;
• manage reagent inventories; comply with laboratory safety requirements; inform first responders;
• describe and reproduce biomedical experiments; and
• assess and disseminate information about toxicity risks of chemical reagents and consumer products.
A working committee of the International Union of Pure and Applied Chemistry (IUPAC) is close to for-
malizing “Mixtures InChI” (or MInChI), which will extend the International Chemical Identifier (InChI) to be-
come the first standard to encompass mixtures. MInChI will effectively index mixtures in the same way that
InChI indexes individual compounds.
In Phase 1 CDD developed the data structures and software necessary to enable adoption and utilization
of MInChI and create the first general-purpose system for recording information about chemical mixtures that
is computable and interoperable. In Phase 2 CDD will continue to develop a sophisticated automated transla-
tion tool that will accurately convert legacy catalogs of chemical mixtures from plaintext descriptions or ad hoc
formats so that they are properly represented in a machine readable format that can in turn be easily rendered
into MInChI identifiers. The broad vision is to help industry to overcome the barriers to adoption so that ma-
chine readable mixture descriptions can quickly deliver benefits for drug discovery, chemical safety, and toxi-
cology.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BARRY A BUNIN其他文献
BARRY A BUNIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BARRY A BUNIN', 18)}}的其他基金
Automated Molecular Identity Disambiguator (AutoMID)
自动分子身份消歧器 (AutoMID)
- 批准号:
10357906 - 财政年份:2020
- 资助金额:
$ 74.87万 - 项目类别:
Automated Molecular Identity Disambiguator (AutoMID)
自动分子身份消歧器 (AutoMID)
- 批准号:
10569639 - 财政年份:2020
- 资助金额:
$ 74.87万 - 项目类别:
Intelligent Chemical Structure Browser for Drug Discovery and Optimization
用于药物发现和优化的智能化学结构浏览器
- 批准号:
10241834 - 财政年份:2019
- 资助金额:
$ 74.87万 - 项目类别:
A Robust, Secure Framework to Effortlessly Bind Distributed Databases and Analysis Tools into Tightly Integrated Translational Drug Discovery Computational Platforms
一个强大、安全的框架,可以轻松地将分布式数据库和分析工具绑定到紧密集成的转化药物发现计算平台中
- 批准号:
10484172 - 财政年份:2019
- 资助金额:
$ 74.87万 - 项目类别:
A Robust, Secure Framework to Effortlessly Bind Distributed Databases and Analysis Tools into Tightly Integrated Translational Drug Discovery Computational Platforms
一个强大、安全的框架,可以轻松地将分布式数据库和分析工具绑定到紧密集成的转化药物发现计算平台中
- 批准号:
10685358 - 财政年份:2019
- 资助金额:
$ 74.87万 - 项目类别:
Intelligent Chemical Structure Browser for Drug Discovery and Optimization
用于药物发现和优化的智能化学结构浏览器
- 批准号:
10386918 - 财政年份:2019
- 资助金额:
$ 74.87万 - 项目类别:
Novel deep learning strategy to better predict pharmacological properties of candidate drugs and focus discovery efforts
新颖的深度学习策略可以更好地预测候选药物的药理学特性并集中发现工作
- 批准号:
10133177 - 财政年份:2018
- 资助金额:
$ 74.87万 - 项目类别:
Novel deep learning strategy to better predict pharmacological properties of candidate drugs and focus discovery efforts
新颖的深度学习策略可以更好地预测候选药物的药理学特性并集中发现工作
- 批准号:
10004481 - 财政年份:2018
- 资助金额:
$ 74.87万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 74.87万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 74.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 74.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 74.87万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 74.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 74.87万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 74.87万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 74.87万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 74.87万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 74.87万 - 项目类别:
Standard Grant